Consolidated Statement of Changes in Equity
For the years ended December 31, 2019 and 2018
| 2019 (SAR ’000) | |||||||||
| Notes | Share capital |
Statutory reserve |
Treasury shares |
Other reserves |
Retained earnings |
Shareholders’ equity |
Tier I Sukuk |
Total equity |
|
| Balances at the beginning of the year as previously reported | 41 (b) | 7,500,000 | 4,928,000 | (787,536) | (192,056) | 205,268 | 11,653,676 | 1,785,000 | 13,438,676 |
| Retroactive effect of other adjustments | 41 (b) | – | – | – | – | (32,608) | (32,608) | – | (32,608) |
| Balances at the beginning of the year as restated | 41 (b) | 7,500,000 | 4,928,000 | (787,536) | (192,056) | 172,660 | 11,621,068 | 1,785,000 | 13,406,068 |
| Net income | – | – | – | – | 239,461 | 239,461 | – | 239,461 | |
| Total other comprehensive income | – | – | – | 522,033 | – | 522,033 | – | 522,033 | |
| Total comprehensive income | – | – | – | 522,033 | 239,461 | 761,494 | – | 761,494 | |
| Treasury shares purchased | 39 | – | – | (253,531) | – | – | (253,531) | – | (253,531) |
| Tier I Sukuk proceeds | 38 | – | – | – | – | – | – | 215,000 | 215,000 |
| Tier I Sukuk costs | – | – | – | – | (122,024) | (122,024) | – | (122,024) | |
| Transfer to statutory reserve | 18 | – | 60,000 | – | – | (60,000) | – | – | – |
| Balances at the end of the year | 7,500,000 | 4,988,000 | (1,041,067) | 329,977 | 230,097 | 12,007,007 | 2,000,000 | 14,007,007 | |
The accompanying Notes 1 to 44 form an integral part of these Consolidated Financial Statements.
| 2018 (SAR ’000) | ||||||||||
| Notes | Share capital |
Statutory reserve |
Treasury shares |
Other reserves |
Retained earnings |
Shares held for employee options, net |
Shareholders’ equity |
Tier I Sukuk |
Total equity |
|
| Balances at the beginning of the year | 7,500,000 | 4,563,000 | – | 204,478 | 1,284,858 | (58,269) | 13,494,067 | 785,000 | 14,279,067 | |
| Effect of the adoption of IFRS 9 on January 1, 2018 | – | – | – | 50,603 | (873,159) | – | (822,556) | – | (822,556) | |
| Balances at the beginning of the year as adjusted | 7,500,000 | 4,563,000 | – | 255,081 | 411,699 | (58,269) | 12,671,511 | 785,000 | 13,456,511 | |
| Net income | 41 (a) | – | – | – | – | 575,897 | – | 575,897 | – | 575,897 |
| Total other comprehensive loss | – | – | – | (373,735) | – | – | (373,735) | – | (373,735) | |
| Total comprehensive (loss) income | – | – | – | (373,735) | 575,897 | – | 202,162 | – | 202,162 | |
| Gains on sales of FVOCI equity investments | 6 (a) | – | – | – | (73,402) | 73,402 | – | – | – | – |
| Foreign shareholder income tax reimbursements | – | – | – | – | 21,566 | – | 21,566 | – | 21,566 | |
| Dividends paid | 26 | – | – | – | – | (450,000) | – | (450,000) | – | (450,000) |
| Net movement in shares held for employee options | 37 (b) | – | – | – | – | – | 58,269 | 58,269 | – | 58,269 |
| Treasury shares purchased | 39 | – | – | (787,536) | – | – | – | (787,536) | – | (787,536) |
| Tier I Sukuk proceeds | 38 | – | – | – | – | – | – | – | 1,000,000 | 1,000,000 |
| Tier I Sukuk costs | – | – | – | – | (94,904) | – | (94,904) | – | (94,904) | |
| Transfer to statutory reserve | 18 | – | 365,000 | – | – | (365,000) | – | – | – | – |
| Balances at the end of the year | 41 (b) | 7,500,000 | 4,928,000 | (787,536) | (192,056) | 172,660 | – | 11,621,068 | 1,785,000 | 13,406,068 |
The accompanying Notes 1 to 44 form an integral part of these Consolidated Financial Statements.